Cited by 485Blockchain Technology Applications and SecurityArtificial Intelligence in Healthcare and EducationBlockchain Technology in Education and Learning

Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare

Open access
Mamoshina, Polina, Ojomoko, Lucy, Yanovich, Yury, Ostrovski, Alex, Botezatu, Alex, Prikhodko, Pavel, Izumchenko, Eugene, Aliper, Alexander +4 more·2018·Oncotarget

Abstract

// Polina Mamoshina 1,2 , Lucy Ojomoko 1 , Yury Yanovich 3 , Alex Ostrovski 3 , Alex Botezatu 3 , Pavel Prikhodko 3 , Eugene Izumchenko 4 , Alexander Aliper 1 , Konstantin Romantsov 1 , Alexander Zhebrak 1 , Iraneus Obioma Ogu 5 and Alex Zhavoronkov 1,6 1 Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University at Eastern, Baltimore, Maryland, USA 2 Department of Computer Science, University of Oxford, Oxford, United Kingdom 3 The Bitfury Group, Amsterdam, Netherlands 4 Department of Otolaryngology-Head & Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA 5 Africa Blockchain Artificial Intelligence for Healthcare Initiative, Insilico Medicine, Inc, Abuja, Nigeria 6 The Biogerontology Research Foundation, London, United Kingdom Correspondence to: Alex Zhavoronkov, email: // Keywords : artificial intelligence; deep learning; data management; blockchain; digital health Received : October 19, 2017 Accepted : November 02, 2017 Published : November 09, 2017 Abstract The increased availability of data and recent advancements in artificial intelligence present the unprecedented opportunities in healthcare and major challenges for the patients, developers, providers and regulators. The novel deep learning and transfer learning techniques are turning any data about the person into medical data transforming simple facial pictures and videos into powerful sources of data for predictive analytics. Presently, the patients do not have control over the access privileges to their medical records and remain unaware of the true value of the data they have. In this paper, we provide an overview of the next-generation artificial intelligence and blockchain technologies and present innovative solutions that may be used to accelerate the biomedical research and enable patients with new tools to control and profit from their personal data as well with the incentives to undergo constant health monitoring. We introduce new concepts to appraise and evaluate personal records, including the combination-, time- and relationship-value of the data. We also present a roadmap for a blockchain-enabled decentralized personal health data ecosystem to enable novel approaches for drug discovery, biomarker development, and preventative healthcare. A secure and transparent distributed personal data marketplace utilizing blockchain and deep learning technologies may be able to resolve the challenges faced by the regulators and return the control over personal data including medical records back to the individuals.

AI snapshot

Written from the paper’s full text.

TL;DR

This review/position paper surveys next-generation AI and blockchain technologies and proposes a blockchain-enabled decentralized personal health data ecosystem with formal models for data value and a LifePound token. It argues such a marketplace could return control of medical data to individuals, incentivize health monitoring, and accelerate biomedical research, though the proposal is conceptual and not empirically validated.

Key findings

  • Reviews AI methods including DNNs, GANs, RNNs, transfer learning, and one/zero-shot learning, citing examples such as a pathway-based DNN achieving an F1 score of 0.701 for three drug pharmacological classes, an RNN heart-failure model with AUC 0.883, and a CNN cardiac MRI model with average F1 score 97.66%.
  • Introduces data value concepts including combination-, time-, and relationship-value of data, the half-life period of analysis, and a coefficient of relationship where parent-offspring r = 0.5 and grandparent-grandchild r = 0.25; proposes cost functions for single users, groups of users, and dataset purchase.
  • Proposes a blockchain marketplace architecture using the Exonum permissioned blockchain framework, off-chain cloud storage, threshold encryption and Shamir secret sharing, key keepers, data validators, customers, and a utility crypto token called LifePound; Exonum is described as providing throughput on the order of 1,000 transactions per second and BFT consensus tolerating up to 1/3 compromised validators.
  • Presents a roadmap for a decentralized personal health data ecosystem for drug discovery, biomarker development, and preventative healthcare, and speculates governments could use such systems to increase participation in preventative medicine or provide universal basic income.

Methods

  • Narrative review and conceptual design; no empirical study, dataset, or systematic review methodology is reported. It synthesizes literature on AI, highly distributed storage systems, blockchain, HIPAA/privacy regulation, and the Exonum framework.
  • Proposes formal mathematical models for data value (single user, group of users, dataset purchase, and relationship value) and describes client workflows for data upload, validation, and purchase.
  • Analysis is descriptive and architectural; no experiments, benchmarking, implementation results, or prospective validation of the proposed marketplace are reported.

Limitations

  • Stated in the paper: the precise protocol for key-share transmission and storage is out of scope; data safety after purchase is out of scope; user-side key management may be prone to risks such as faulty random number generators, inadequate long-term key storage, and compromised user interfaces; one-shot networks trained on Tox21 failed to achieve predictive power when tested on SIDER; and there is no universal agreement on what constitutes privacy.
  • Evident from the text: the proposed marketplace, LifePound token, and data value model are not empirically tested or implemented in the paper, and no security or performance evaluation of the full ecosystem is provided beyond cited Exonum specifications.
  • Evident from the text: the work is a review/position paper rather than a systematic review or experimental study, so its claims about accelerating biomedical research and returning data control to individuals remain conceptual.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.18632/oncotarget.22345

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 48 cited sources checked · 0 supported · 0 flagged

  • Interpretationcitation

    None of the recent approaches to personalized medicine in oncology and other diseases are truly integrative on the population scale and compare the predictive nature and value of the various data types in the context of biomedicine.

    “none of these approaches are truly integrative on the population scale and compare the predictive nature and value of the various data types in the context of biomedicine.”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [24] Rushing, 2016, Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers, Oncotarget source

      Not checked in the free run.

    • cites [25] Cantor, 2013, From personalized medicine to personalized science: uniting science and medicine for patient-driven, goal-oriented research, Rejuvenation Res source

      Not checked in the free run.

    • cites [26] Im, 2012, Personal omics profiling reveals dynamic molecular and medical phenotypes, Cell source

      Not checked in the free run.

  • Premisecitation

    An adversarial autoencoder trained on molecules with different tumor growth inhibition activity generated molecular fingerprints that matched closely to already known highly effective anticancer drugs such as anthracyclines.

    “Further analysis of the generated molecules showed that new molecular fingerprints are matched closely to already known highly effective anticancer drugs such as anthracyclines.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [41] Zhavoronkov, 2017, The cornucopia of meaningful leads: applying deep adversarial autoencoders for new molecule development in oncology, Oncotarget source

      Not checked in the free run.

  • Premisecitation

    Machine learning techniques utilizing Deep Neural Networks (DNNs) are able to capture high-level dependencies in healthcare data.

    “the machine learning techniques utilizing the Deep Neural Networks (DNNs) are able to capture high-level dependencies in the healthcare data [32].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [32] Zhavoronkov, 2016, Applications of Deep Learning in Biomedicine, Mol Pharm source

      Not checked in the free run.

  • Premisecitation

    Iterative Refinement LSTMs outperformed other models on most Tox21 assays and SIDER side effect.

    “Iterative Refinement LSTMs outperformed other models on most of the Tox21 assays and SIDER side effect.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [51] Pande, 2017, Low Data Drug Discovery with One-Shot Learning, ACS Cent Sci source

      Not checked in the free run.

  • Premisecitation

    A CNN pre-trained on ImageNet and further trained on MRIs of heart achieved an average F1 score of 97.66% for cardiac structure recognition.

    “A CNN pre-trained on the ImageNet was further trained on magnetic resonance images (MRIs) of heart to outline the organ structure [49]. With an average F1 score of 97.66%, the proposed model achieved state-of-the-art cardiac structure recognition.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [49] Ayache, 2015, Fine-tuned convolutional neural nets for cardiac MRI acquisition plane recognition, Comput Methods Biomech Biomed Eng Imaging Vis

      Not checked in the free run.

  • May combine two claims. 35
  • Classified as probably not a substantial claim. 42
  • May combine two claims.

    Premisecitation

    Signaling pathway-based dimensionality reduction allowed for more robust performance on the validation set, while classifiers trained on gene expression data demonstrated a significant decrease in predictive accuracy on the validation set compared to training set performance.

    “signaling pathway-based dimensionality reduction allowed for the more robust performance on the validation set, while classifiers trained on gene expression data demonstrated a significant decrease in predictive accuracy on the validation set compared to the training set performance.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [33] Zhavoronkov, 2016, Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data, Mol Pharm source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.

    Interpretationnone given

    Introduction of new technologies, such as artificial intelligence and blockchain, may enhance and scale up progress in health care sciences and lead to effective and cost-efficient healthcare ecosystems.

    “Introduction of new technologies, such as an artificial intelligence and blockchain, may enhance and scale up the progress in health care sciences and lead to effective and cost-efficient healthcare ecosystems.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The success of initiatives that provide patients with access to their electronic healthcare records, such as OpenNotes, suggests their potential to improve the quality and efficiency of medical care.

    “The success of initiatives that provides patients with the access to their electronic healthcare records, such as OpenNotes, suggests their potential to improve the quality and efficiency of medical care [1, 2].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [1] Lin, 2004, Use of a patient-accessible electronic medical record in a practice for congestive heart failure: patient and physician experiences, J Am Med Inform Assoc source

      Not checked in the free run.

    • cites [2] Walker, 2016, Do Patients Who Access Clinical Information on Patient Internet Portals Have More Primary Care Visits?, Med Care source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    A DNN trained on pathway scores outperformed a DNN trained on the set of landmark genes and achieved an F1 score of 0.701 for the three drug pharmacological classes.

    “DNN trained on the pathway scores outperformed DNN trained on the set of landmark genes and achieved the F1 score, the weighted average of precision and recall, of 0.701 for the three drug pharmacological classes.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [33] Zhavoronkov, 2016, Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data, Mol Pharm source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    An enhanced GAN architecture that included additional molecular parameters such as solubility enabled generation of more chemically diverse molecules and showed improvement in training and generation processes.

    “authors proposed an enhanced architecture that also included additional molecular parameters such as solubility and enabled the generation of more chemically diverse molecules [42]. New model clearly showed the improvement in the training and generation processes”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [42] Zhavoronkov, 2017, druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico, Mol Pharm source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Exonum's service-oriented architecture allows applications to reuse services developed for other Exonum applications, add and reconfigure services, and streamline integration of third-party applications via common transports such as REST+JSON.

    “Due to use of service-oriented architecture, the application could easily reuse services developed for other Exonum applications, add and reconfigure services utilized for the application, etc. The service orientation and direct use of common transports (such as REST + JSON) could allow to streamline integration of third-party applications into the ecosystem provided by the Marketplace.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    Client-side data validation could allow reducing risks associated with man-in-the-middle attacks, including those performed on the server side.

    “Client-side data validation could allow reducing the risks associated with man-in-the-middle attacks, including those when MitM is performed on the server side (e.g., by compromising the user-facing backend of the system).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Networks trained on Tox21 data were tested on SIDER, but none of the one-shot networks achieved any predictive power, highlighting a potential limitation in translation from toxic in vitro assays into the human clinic.

    “networks trained on Tox21 data were tested on SIDER, however none of the one-shot networks achieved any predictive power, highlighting the potential limitation in translation from toxic in vitro assays into the human clinic.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [51] Pande, 2017, Low Data Drug Discovery with One-Shot Learning, ACS Cent Sci source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Exonum's data storage design for auditability could make it easier for clients and auditors, including those with incomplete read access, to audit the system in real time and retrospectively, and the list of auditors could be unknown beforehand and scaled over blockchain operation.

    “Because of design of data storage structures for auditability, Exonum could make it easier for clients and auditors (incl. ones with incomplete read access to data) to audit the system both in real time (incl. intermittently) and retrospectively. Further, the list of auditors could be unknown beforehand, and could be scaled over the course of blockchain operation.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    RNNs were used to predict heart failure of patients based on clinical events in their records; models trained on 12-month clinical history and tested on 6 months demonstrated an AUC of 0.883 and outperformed shallow models.

    “Recently, RNNs were used to predict heart failure of patients based on clinical events in their records [44]. Models trained on 12 month period of clinical history and tested on 6 months demonstrated an Area Under the Curve (AUC) of 0.883 and outperformed shallow models.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [44] Sun, 2017, Using recurrent neural network models for early detection of heart failure onset, J Am Med Inform Assoc source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    Blockchain is very suitable for application in healthcare and other areas where data is very sensitive and strict regulations on how data can be used need to be imposed.

    “This makes blockchain very suitable for application in healthcare and other areas where data is very sensitive and strict regulations on how data can be used need to be imposed.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: By design, blockchain ensures immutability of data, so once recorded, data in any given block cannot be modified afterwards without alteration of all subsequent blocks and agreement of the members of the network.
  • May combine two claims.

    Premisecitation

    HIPAA requires an institutional review board to approve the use of data, and this could introduce some degree of complexity to data use.

    “HIPAA requires an institutional review board to approve the use of data, and this could simply introduce some degree of complexity to data use [57].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [57] Just, Whitaker. Addressing the Challenges of Translational and Clinical Research Data Management. Health Catalyst. 2015. Available from: https://www.healthcatalyst.com/addressing-challenges-clinical-research-data-management.

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationreasoning

    The availability of real-time and retrospective authorization tools with guarantees of data authenticity could reduce costs of auditing and monitoring processes.

    “The availability of real-time and retrospective authorization tools with guarantees of data authenticity could reduce costs of auditing and monitoring processes.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationreasoning

    Because of its integrity and immutability, blockchain could be used as an open, distributed ledger and can record transactions between different parties or networked database systems in an efficient, verifiable and permanent manner.

    “Because of its integrity and immutability, blockchain could be used as an open, distributed ledger and can record transactions between different parties or networked database systems in an efficient, verifiable and permanent manner.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: By design, blockchain ensures immutability of data, so once recorded, data in any given block cannot be modified afterwards without alteration of all subsequent blocks and agreement of the members of the network.
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Exonum uses a BFT Bitcoin anchoring algorithm that periodically outputs the hash digest of a recent block to Bitcoin, authenticated by a supermajority, with chaining similar to paper-based anchoring [75].

    “Exonum uses a BFT Bitcoin anchoring algorithm, which is packaged as a separate service. The algorithm periodically outputs the hash digest of a recent block on an Exonum blockchain, which commits to the entire blockchain state and transaction history, in a transaction on the Bitcoin blockchain. The anchoring transaction has a well-defined form and must be authenticated by a supermajority of valid”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [75] Buldas, Lipmaa. Schoenmakers - Public Key Cryptography B, 2000. Optimally efficient accountable time-stamping. Springer. 2000. Available from: http://link.springer.com/content/pdf/10.1007/b75033.pdf#page=304. source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Interpretationreasoning

    One-time combination of data provides a nutritious feed for artificial intelligence, allowing creation of powerful algorithms for effective and precise detection of different human health states.

    “One-time combination of date provides a very nutritious feed for artificial intelligence, allowing to create powerful algorithms of effectively and precisely detection different human health states.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
    • Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
  • May combine two claims.

    Premisecitation

    Genome analysis provides important heredity information but has low value for prediction of dynamic changes in the organism compared to epigenome [80] or transcriptome [81].

    “For example, genome analysis provides an important information on heredity, but due to it relative stability has a low value for prediction of dynamic changes in the organism compared to epigenome [80] or transcriptome [81].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [80] Tyson, 2013

      Not checked in the free run.

    • cites [81] Passos, 2015

      Not checked in the free run.

    • Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
    • Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
  • Classified as probably not a substantial claim.

    Premisecitation

    Following 360° health, the more different parameters analyzed at the same time, the more detailed and voluminous the overall picture [82].

    “Following the principles of 360° health introduced by the NHS [82], the more different parameters are analyzed at the same time, the more detailed and voluminous the overall picture is.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [82] Whitehead. 360° of health data: Harnessing big data for better health. 2014. Available from: http://www.abpi.org.uk/our-work/library/medical-disease/Documents/360%20Degrees%20of%20Health%20Data.pdf.

      Not checked in the free run.

    • Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
    • Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisenone given

    The validator set is reconfigurable; validators can be added or removed by supermajority agreement, and key rotation can be done.

    “The validator set is reconfigurable; validators could be added or removed by the agreement of the supermajority of existing validators. The same procedure could be used for key rotation for validators.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning

    Merkelized collections allow creation of compact logarithmic cryptographic proofs of presence and absence of items in the collection.

    “This construction allows to create compact (logarithmic wrt the number of elements in the collection) cryptographic proofs of presence (and absence in the case of sets/maps) of items in the collection.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationreasoning

    All Merkelized collections of a service can be committed to a single hash digest, and all services to a blockchain-level hash digest committing to all data in all Merkelized collections, allowing proofs tied to a single root of trust.

    “Similarly, commitments of all services within the blockchain could be collected into a single blockchain-level hash digest, which would commit to all data in all Merkelized collections within the blockchain state. For all intents and purposes, the resulting blockchain-level hash digest is the hash (commitment) of the entire blockchain state. This would allow to create proofs of existence or”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Combination of data types, especially the sum of low diagnostics data, provides a multi-level overview, better understanding of complex multifactorial conditions, and leads to faster diagnostics [78,79].

    “The combination of data types, especially the sum of low diagnostics data, provides a multi-level overview and better understanding of complex multifactorial conditions, and also leads to a faster diagnostics [78, 79].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [78] Liang, 2016, Nucleic Acid Amplification Testing and Sequencing Combined with Acid-Fast Staining in Needle Biopsy Lung Tissues for the Diagnosis of Smear-Negative Pulmonary Tuberculosis, PLoS One source

      Not checked in the free run.

    • cites [79] Huang, 2015, Identification of Breast Cancer Using Integrated Information from MRI and Mammography, PLoS One source

      Not checked in the free run.

    • Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
    • Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    Exonum's Requests algorithm allows a validator to restore consensus-related information from other validators, improving system liveness.

    “Requests: Requests algorithm allows a validator to restore consensus-related information from other validators by utilizing the fact that all messages are digitally signed. This has a positive effect on system liveness.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Study design and conductnone given

    Transactions are necessarily authenticated by their originators with public-key digital signatures to ensure integrity and real-time and retrospective universal verifiability.

    “Transactions are necessarily authenticated by their originators with the help of public-key digital signatures to ensure their integrity, as well as real-time and retrospective universal verifiability.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    The Exonum network continues operating even if up to 1/3 validators are hacked, compromised or switched off, so there is no single point of failure and transaction processing is fully decentralized.

    “The Exonum network would continue operating even if up to 1/3 validators are hacked, compromised or switched off. Hence, there is no single point of failure in the network; the whole process of transaction processing is fully decentralized.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [73] Pease, Shostak, Lamport. Reaching Agreement in the Presence of Faults. J ACM. New York, NY, USA: ACM; 1980; 27: 228-34.

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Due to universal verifiability of transactions and proofs, clients may connect to a single node for all requests; a malicious node cannot forge proofs for read requests but could delay transaction processing.

    “Due to universal verifiability of transactions and proofs, clients may connect to a single node for all requests. Note that maliciously acting node cannot forge proofs for read requests; but it could delay transaction processing by not broadcasting transactions received from the client.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Under the assumption of unforgeable public-key digital signatures and a partially synchronous network, Exonum's consensus algorithm provides safety and liveness as defined in [74], with safety not depending on partial synchronicity.

    “The consensus algorithm works under the assumption of unforgeable public-key digital signatures and a partially synchronous network. Under these conditions, the algorithm provides safety and liveness as defined in [74], with safety not depending on partial synchronicity.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [74] Kwon. Tendermint: consensus without mining. 2015. Available from: http://tendermint.com/docs/tendermint.pdf.

      Not checked in the free run.

    • The authors state this as an assumption: The consensus algorithm works under the assumption of unforgeable public-key digital signatures and a partially synchronous network.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    Exonum's unbounded voting rounds help decrease delays when network connection among validators is unstable.

    “Unbounded rounds: Voting rounds have a fixed start time, but do not have a definite end time. A round ends only when the next block is received or committed locally. This helps decrease delays when the network connection among validators is unstable.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Interactions in the marketplace are registered on a blockchain as transactions; the blockchain contains hashes used to timestamp and provide non-repudiation, not opened personal information.

    “Interactions in the marketplace are registered on a blockchain in the form of transactions. Blockchain by itself does not contain any opened personal information. It contains hashes which could be used to timestamp and provide a reasonable level of non-repudiation for all actions at the marketplace.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
  • May combine two claims.

    Interpretationreasoning

    Combining various biomarkers and linking them to age will provide the basis for a platform able to provide integrative analysis of health status, assess data quality, and identify fake data.

    “Hence, combining various biomarkers and linking them to age will provide the basis for platform able to provide integrative analysis of health status, assess data quality and even identify fake data.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Chronological age is one of the most important factors affecting morbidity and mortality in humans.
    • Rests on an assumption: Age is the closest estimate of a health status of a person.
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Interpretationnone given

    The promise of such a solution is the opportunity for users to take ownership of their data and access privileges and sell their data directly to consumers for fair value.

    “The promise of such solution is the opportunity for users to take ownership of their data and access priviledges and even allow them to sell their data directly to the consumers of data for the fair value of data.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    DNNs trained on multi-modal data ranging from photographs, videos, blood tests, omics, activity, smell and sweat during aging capture many biologically-relevant features about the group, individual, organ, tissue or molecules.

    “The DNNs trained on the multi-modal data ranging from photographs, videos, blood tests, “omics”, activity and even smell and sweat during aging capture the many biologically-relevant features about the group, individual, organ, tissue or even a set of molecules.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Chronological age is one of the most important factors affecting morbidity and mortality in humans.
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationreasoning

    For distant relatives, r→0 and almost will not contribute to the cost function; for twins r=1 and at the beginning it will double the cost of data; cost grows with number of close relatives using the platform.

    “For distant relatives, r → 0 and almost will not contribute to the cost function of data, however, for a very close relative such as twins, r is equal to 1 and at the beginning, it will double the cost of data. The cost of data will grow with a number of close relatives that are using the platform and contributing their data.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Biomedical data obtained for relatives is commonly more valuable than the same data obtained from unrelated individuals.
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Interpretationreasoning

    The proposed high-level architecture with individual DNN predictors per data type and a multi-modal one-shot learning DNN allows accurate age prediction and feature importance analysis, informing relative cost of biomarkers.

    “This architecture allows not only for accurate age prediction, but also for feature importance analysis. Results of such analysis across all predictors will tell about the importance of each individual biomarker and may inform its relative ‘cost’.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Chronological age is one of the most important factors affecting morbidity and mortality in humans.
    • Rests on an assumption: Age is the closest estimate of a health status of a person.
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationreasoning

    Application of the data value model makes it possible to convert Big Data into Apprised Data.

    “Thus, the application of the data value model makes it possible to convert Big Data into Apprised Data.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
    • Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
  • May combine two claims.

    Premisecitation

    Timestamping is achieved with blockchain anchoring [52] and accountable timestamping [59]; non-repudiation with digital signing and a blockchain-based PKI.

    “The former is achieved with the help of blockchain anchoring [52] and other accountable timestamping [59] techniques; the latter - with the help of digital signing and a blockchain-based PKI.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [52] Cory. Cross-Border Data Flows: Where Are the Barriers, and What Do They Cost? Available from: https://itif.org/publications/2017/05/01/cross-border-data-flows-where-are-barriers-and-what-do-they-cost.

      Not checked in the free run.

    • cites [59] Office For Civil. Your Rights Under HIPAA. HHS.gov. US Department of Health and Human Services. 2017. Available from: https://www.hhs.gov/hipaa/for-individuals/guidance-materials-for-consumers/index.html.

      Not checked in the free run.

    • Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Interpretationnone given

    A blockchain-based system can dramatically simplify data acquisition, allowing users to upload data directly and give permission if bought through the system using a transparent price formula determined by the data value model, and guarantee fair tracking of data usage.

    “A blockchain-based system can dramatically simplify data acquisition process. They allow user to upload his data directly to the system and give his permission to use his data if it was bought through the system using transparent price formula determined by data value model. Also it would guarantee fair tracking of all data usage activity.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
  • May combine two claims.

    Premisecitation

    A multitude of biomarkers linked to disease are strongly correlated with age; e.g., triglycerides, HbA1c, waist circumference, IL-6 increase with age, while albumin, IGF and creatinine clearance decrease [84,85].

    “For instance, triglycerides, glycated hemoglobin (HbA1c), waist circumference, IL-6 increase with age, but other parameters like albumin, IGF and creatinine clearance go in an opposite direction [84, 85].”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [84] Perls, 2017, Biomarker signatures of aging, Aging Cell source

      Not checked in the free run.

    • cites [85] Weinstein, 2011, Age-Related Changes in Biomarkers: Longitudinal Data from a Population-Based Sample, Res Aging source

      Not checked in the free run.

    • Rests on an assumption: Chronological age is one of the most important factors affecting morbidity and mortality in humans.
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationreasoning

    Exchanging data for currency may be problematic due to the need for massive numbers of micro-transactions in multiple countries and among many types of data market participants.

    “However, exchanging the data for currency may be problematic for many reasons including the need to perform a massive number of micro-transactions in multiple countries and among a large number of different types of the data market market participants.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
  • May combine two claims.

    Premisecitation

    Treating aging as a disease to train deep neural networks facilitates transfer learning on individual diseases using a much smaller number of samples; first proposed by Zhavoronkov et al in 2015 [93], this technique can reconstruct datasets with missing or incorrect features.

    “In addition, treating aging as a disease to train the deep neural networks to capture the most important biological properties of the age-related changes that transpire during aging using the deep neural networks facilitates for transfer learning on individual diseases using a much smaller number of samples. First proposed by Zhavoronkov et al in 2015 [93], this technique can be used to”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [93] Fedintsev, 2017, A review of the biomedical innovations for healthy longevity, Aging (Albany NY) source

      Not checked in the free run.

    • Rests on an assumption: Chronological age is one of the most important factors affecting morbidity and mortality in humans.
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Interpretationnone given

    To ensure quality of user data, third-party data validators are needed; they check data quality and provide customers with a guarantee of user data validity.

    “To ensure the quality of the data provided by users, third party is needed - data validators, experts who are first buyers of the data. Data validators check the data quality and provide customers with a guarantee of user data validity.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    Every Dataset has its own critical representative level, depending on the type of data, their quality, and patient profile.

    “Every Dataset has it’s own critical representative level, critical level depends on the type of data, their quality, and patient profile.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
    • Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    Data obtained in the same or short period of time have greater representation and predictive value.

    “Data obtained it the same or short period of time have greater representation and predictive value, that’s why we introduce term time value of data.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
    • Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
    • Rests on an assumption: Sampling time is an important component of any medical analysis, allowing accurate description of the state of human health at the moment.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationcitation

    To ensure security and privacy, data uploaded by users to cloud storage would be encrypted on the user side using a threshold encryption scheme [97-100].

    “To ensure security and privacy, the data uploaded by users to the cloud storage would be encrypted on the user side using a threshold encryption scheme [97-100].”
    Quote in the paperNot a substantial claim0 of 4 sources checked
    • cites [97] Shamir. Communications of the ACM A. 1979. How to share a secret. 1979 Available from: http://dl.acm.org/citation.cfm?id=359176.

      Not checked in the free run.

    • cites [98] Blakley. Proceedings of the national computer 1979. Safeguarding cryptographic keys. 1979. Available from: https://pdfs.semanticscholar.org/32d2/1ccc21a807627fcb21ea829d1acdab23be12.pdf.

      Not checked in the free run.

    • cites [99] Robling Denning, 1982

      Not checked in the free run.

    • cites [100] Desmedt, 1992

      Not checked in the free run.

    • Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationreasoning

    The formal data value model allows establishing a proper cost for using a given data combination, enabling creation of a formal medical data transaction model and a medical data marketplace.

    “In this paper we introduce a formal model that allows to evaluate data value that takes into account combination and time parameters of data. Based on the value model one may establish a proper cost for using the given data combination, and this in turn allows for creation of formal medical data transaction model to create medical data marketplace.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
    • Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
  • May combine two claims.

    Premisecitation

    Cholesterol check is valid for only five years or less if a patient is at higher risk of heart disease [83], while genome profile is valid for the whole life, so genome analysis has a longer half-life period than basic cholesterol blood test.

    “For example, according to one of largest medical practice and research center, Mayo Clinic, cholesterol check is valid for only five years or less if a patient at the higher risk of heart disease [83]. While, the genome profile is valid for the whole life of the patient, so genome analysis has longer half-life period than basic cholesterol blood test.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [83] Mayo Clinic. Cholesterol test. Why it’s done. Mayo Clinic. 2016 [cited 2017 Oct 15]. Available from: http://www.mayoclinic.org/tests-procedures/cholesterol-test/details/why-its-done/icc-20169529.

      Not checked in the free run.

    • Rests on an assumption: Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.
    • Rests on an assumption: Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Blockchain technology has been proposed as a medium for health care data storage solutions [94,95] and as a tool for improving transparency in clinical trials [96].

    “Gained a substantial attention in recent years T, the blockchain technology gained substantial popularity in recent years primarily due to the popularity of the Bitcoin crypto currency, was previously has been proposed as a medium for health care data storage solutions [94, 95] and as a tool for to improving thee transparency in clinical trials [96].”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [94] Ohno-Machado, 2017, Blockchain distributed ledger technologies for biomedical and health care applications, J Am Med Inform Assoc source

      Not checked in the free run.

    • cites [95] Schulz, 2017, Blockchain Technology: Applications in Health Care, Circ Cardiovasc Qual Outcomes source

      Not checked in the free run.

    • cites [96] Cimpoesu, 2016, Improving data transparency in clinical trials using blockchain smart contracts, F1000 Res source

      Not checked in the free run.

    • Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Interpretationnone given

    Blockchain technology enables the creation of a distributed and secure ledger of personal data, where patients are in control, own their data, and monitoring of access privileges and understanding of who looked at the data.

    “Blockchain technology enables the creation of a distributed and secure ledger of personal data, where patients are in control, own their data, and monitoring of access privileges and understanding of who looked at the data.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Presently, only a few patients worldwide have comprehensive datasets containing clinical history combined with genetic, blood biochemistry, cell count, lifestyle, drug and supplement use data, because they do not see the value in this data and do not get tested regularly.
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Interpretationnone given

    Blockchain and AI open new paradigms for health data ecosystems.

    “Blockchain and AI open new paradigms for health data ecosystems (Figure 12).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Anomalies in data could be linked to health conditions, so both unsupervised and time-series approaches could be used for pathology detection in health recordings.

    “Anomalies in the data could also be linked to health conditions, so both those approaches could be used for pathology detection in health recordings [103, 104].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [103] Vig, 2015, Anomaly detection in ECG time signals via deep long short-term memory networks, 2015 IEEE International Conference on Data Science and Advanced Analytics (DSAA)

      Not checked in the free run.

    • cites [104] Liu, 2016, Research on Healthy Anomaly Detection Model Based on Deep Learning from Multiple Time-Series Physiological Signals, Sci Program

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.

    Interpretationnone given

    The introduction of the blockchain-based data ecosystem may help ensure that individuals take control over their data and companies and research institutions may acquire data more freely, reducing the need for regulators to interfere.

    “The introduction of the blockchain-based data ecosystem may help ensure that the individuals take control over their data and companies and research institutions may acquire data more freely reducing the need for the regulators to interfere.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Data security and data privacy are major challenges in data-driven healthcare.
    • Rests on an assumption: Consumer, healthcare, and research companies require data from many individuals to train their deep neural networks.
    • Rests on an assumption: Companies with the largest datasets acquire data in ways that may not be transparent to individuals, and often companies and individuals do not understand the value of this data.
    • Rests on an assumption: Regulators often set up barriers for consumer data collection and storage, substantially inhibiting the propagation of recent AI advances into clinical practice.
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.

    Interpretationreasoning

    Blockchain-based PKI for logically well-known users could base on well-established measures for secure key management and be augmented with blockchain-based smart contracting.

    “Blockchain-based PKI for logically “well-known” users (e.g., blockchain validators, data validators, key keepers, etc.) could base on well-established measures for secure key management (e.g., key sharing, use of specialized hardware for key storage, etc.).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    The value of the various data types may depend on the application.

    “The value of the various data types may depend on the application.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The value of various types of data, combinations of data types, and time value of data is poorly understood and often debated.
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationreasoning

    Blockchain technology allows for the creation of a data-driven marketplace, where patients can earn tangible rewards for making their data available to application developers, pharmaceutical and consumer companies, and research institutions and generating new data through regular and comprehensive tests and checkups.

    “Most importantly, blockchain technology allows for the creation of a data-driven marketplace, where patients can earn tangible rewards for making their data available to the application development community, pharmaceutical and consumer companies, and research institutions and generating new data through regular and comprehensive tests and checkups.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Presently, only a few patients worldwide have comprehensive datasets containing clinical history combined with genetic, blood biochemistry, cell count, lifestyle, drug and supplement use data, because they do not see the value in this data and do not get tested regularly.
    • Rests on an assumption: Pharmaceutical and consumer companies are willing to pay substantial amounts for large numbers of personal data records required to train their AI.
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    The use of authenticated communication channels to transmit key shares could achieve forward secrecy, i.e., non-compromise of encrypted user data even if key keepers' long-term asymmetric keys become compromised.

    “The use of authenticated communication channels to transmit key shares could allow to achieve forward secrecy, i.e., non-compromise of the encrypted user data even if the key keepers’ long-term asymmetric keys would become compromised (incl. the compromise of the underlying asymmetric cryptosystem, e.g., with the advent of quantum computing).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Interpretationnone given

    The security of the described marketplace setup relies on the security of the hash function, public-key signature schemes, symmetric ciphers, and secret sharing schemes used.

    “The security of the described setup relies on the security of utilized crypto-primitives: the hash function and public-key signature scheme(s) utilized in the marketplace blockchain construction, as well as the symmetric cipher(s) and the secret sharing scheme(s) used for encrypting user data.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    The problem of unbalanced labelled datasets for anomaly detection could be solved with zero and one shot learning.

    “Still, the problem could be solved with help of zero and one shot learning.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationreasoning

    For insurance companies, the value of a recent picture of the patient may significantly exceed the value of the genome, since it may be more predictive of the patient's age, health status and mortality.

    “For example, for the insurance companies, while the cost of data generation may be significantly higher for the genome compared to a selfie, the value of the recent picture of the patient may significantly exceed the value of the genome, since it may be more predictive of the patient’s age, health status and mortality.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Recent advances in AI have enabled highly accurate predictors of biologically relevant features such as age, race, and sex from simple data types such as selfies and blood tests.
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Interpretationnone given

    The combination of these data types will be considerably more valuable than the value of these data types individually.

    “However, the combination of these data types will be considerably more valuable than the value of these data types individually.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Recent advances in AI have enabled highly accurate predictors of biologically relevant features such as age, race, and sex from simple data types such as selfies and blood tests.
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    User-side key management for data encryption and authentication of blockchain transactions may be prone to various risks, including faulty random number generation, inadequate long-term key storage, and compromised user interfaces.

    “The user-side key management for data encryption and authentication of blockchain transactions may be prone to various risks (e.g., a faulty random number generator resulting in generation of keys with insufficient entropy; inadequate security for long-term key storage; compromises of the user interface).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    One major reason for integrating cloud storage is to provide off-chain storage for large biomedical data files such as CT scans or MRIs, where one file can reach 50 Mb.

    “One of the major reasons for integrating cloud storage into the ecosystem is to provide an off-chain storage solution especially for large biomedical data files, such as CT scans or MRIs, where the size of one data file could reach 50 Mb.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationnone given

    Cloud storage may require authentication for read and write access, preferably based on PKI established on the marketplace blockchain.

    “The cloud storage may require authentication for read and write access to data, which in a preferable setup would be based on the PKI established on the marketplace blockchain.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: One major problem for healthcare is data exchange and ability to use data in research and commercial projects.
62 of 62
  • The paper relies on this without support.

    Presently, patients do not have control over the access privileges to their medical records and remain unaware of the true value of the data they have.

    “Presently, the patients do not have control over the access privileges to their medical records and remain unaware of the true value of the data they have.”
  • The paper relies on this without support.

    Novel deep learning and transfer learning techniques are turning any data about the person into medical data, transforming simple facial pictures and videos into powerful sources of data for predictive analytics.

    “The novel deep learning and transfer learning techniques are turning any data about the person into medical data transforming simple facial pictures and videos into powerful sources of data for predictive analytics.”
  • The paper relies on this without support.

    By design, blockchain ensures immutability of data, so once recorded, data in any given block cannot be modified afterwards without alteration of all subsequent blocks and agreement of the members of the network.

    “By design, blockchain is made to ensure immutability of the data. So once recorded, the data in any given block cannot be modified afterwards without the alteration of all subsequent blocks and the agreement of the members of the network.”
  • The paper relies on this without support.

    Exonum is an open-source blockchain framework oriented towards permissioned blockchain applications with wide read access to blockchain data.

    “Exonum (https://exonum.com, from Latin exonumia, numismatic items other than coins and paper money) is an open-source blockchain framework oriented towards permissioned blockchain applications with wide read access to blockchain data.”
  • The paper relies on this without support.

    The transfer of medical records from paper to electronic formats could increase the chances of individuals accessing, using, or disclosing sensitive personal health data.

    “The transfer of medical records from paper to electronic formats could increase the chances of individuals accessing, using, or disclosing sensitive personal health data.”
  • The paper relies on this without support.

    Exonum provides substantially higher throughput capacity (order of 1,000 transactions per second) and ability to encode complex transactional logic compared to permissionless blockchains and frameworks with domain specific language/virtual machine indirection.

    “Compared to permissionless blockchains and frameworks with domain specific language/virtual machine indirection, Exonum provides substantially higher throughput capacity (order of 1,000 transactions per second), and ability to encode complex transactional logic, incl. interaction with external components.”
  • The authors state this as an assumption.

    The consensus algorithm works under the assumption of unforgeable public-key digital signatures and a partially synchronous network.

    “The consensus algorithm works under the assumption of unforgeable public-key digital signatures and a partially synchronous network.”
  • The paper relies on this without support.

    Each type of medical data and their combinations have relevant value depending on quality of the medical records and biological significance for certain disease condition.

    “Each type of data (basic blood test, basic urine test, MRI, electroencephalogram, electrocardiogram, genome, transcriptome, microbiome etc.) and their combinations have relevant value, depending on quality of the medical records and its biological significance for certain disease condition (Figure 2).”
  • The paper relies on this without support.

    Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.

    “Different types of medical data have their own predictive value, representative sensitivity, prediction rate and weight.”
  • The paper relies on this without support.

    Sampling time is an important component of any medical analysis, allowing accurate description of the state of human health at the moment.

    “Sampling time is an important component of any medical analysis, which allows to accurately describe the state of the human health at the moment.”
  • The paper relies on this without support.

    Biomedical data obtained for relatives is commonly more valuable than the same data obtained from unrelated individuals.

    “Eventually,The biomedical data obtained for relatives is commonly more valuable than the same data obtained from the unrelated individuals.”
  • The paper relies on this without support.

    Chronological age is one of the most important factors affecting morbidity and mortality in humans.

    “Chronological age is a feature possessed by the every living organism and one of the most important factors affecting the morbidity and mortality in humans.”
  • The paper relies on this without support.

    Age is the closest estimate of a health status of a person.

    “Ultimately, age is the closest estimate of a health status of a person.”
  • The paper relies on this without support.

    One major problem for healthcare is data exchange and ability to use data in research and commercial projects.

    “One of the major problem for healthcare is data exchange and ability to use data in research and commercial projects.”
  • The paper relies on this without support.

    The value of various types of data, combinations of data types, and time value of data is poorly understood and often debated.

    “The value of the various types of data, combinations of the various data types, time value of one data type and time value of combination of data types is poorly understood and often debated.”
  • The paper relies on this without support.

    Recent advances in AI have enabled highly accurate predictors of biologically relevant features such as age, race, and sex from simple data types such as selfies and blood tests.

    “Recent advances in artificial intelligence enabled the creation of highly accurate predictors of biologically relevant features such as age, race and sex from very simple data types such as selfies, blood tests and such.”
  • The paper relies on this without support.

    Presently, only a few patients worldwide have comprehensive datasets containing clinical history combined with genetic, blood biochemistry, cell count, lifestyle, drug and supplement use data, because they do not see the value in this data and do not get tested regularly.

    “Presently, only a few patients worldwide have the comprehensive data sets containing their clinical history combined with the genetic, blood biochemistry and cell count profiles, lifestyle data, drug and supplement use and other data types, because they do not see the value in this data and do not get tested regularly.”
  • The paper relies on this without support.

    Pharmaceutical and consumer companies are willing to pay substantial amounts for large numbers of personal data records required to train their AI.

    “On the other hand, the pharmaceutical and consumer companies alike are willing to pay substantial amounts for the large numbers of personal data records required to train their AI.”
  • The paper relies on this without support.

    Data security and data privacy are major challenges in data-driven healthcare.

    “One of the major challenges in the data-driven healthcare is data security and data privacy.”
  • The paper relies on this without support.

    Consumer, healthcare, and research companies require data from many individuals to train their deep neural networks.

    “Both the consumer, healthcare and research companies require the data of the many individuals to train their deep neural networks.”
  • The paper relies on this without support.

    Companies with the largest datasets acquire data in ways that may not be transparent to individuals, and often companies and individuals do not understand the value of this data.

    “The companies with the largest data sets acquire the data in the ways that may not be very transparent to the individuals and often the companies and the individuals do not understand the value of this data.”
  • The paper relies on this without support.

    Regulators often set up barriers for consumer data collection and storage, substantially inhibiting the propagation of recent AI advances into clinical practice.

    “The regulators often set up the barriers for the consumer data collection and storage substantially inhibiting the propagation of the recent advances in AI into the clinical practice (Figure 11).”
  • The paper relies on this without support.

    Deep neural networks could be biased by the data they are trained on.

    “While the DNNs are considered to have an exceptional generalization ability, they could be biased by the data they are trained on.”
23 of 23

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mamoshina et al.'s framework for anomaly detection may underperform when datasets are not labelled.

    “Mamoshina et al. (2018) also acknowledge that their proposed framework directed at detecting anomalies may underperform in certain cases where datasets are not labelled.”

    From Blockchain in healthcare: A systematic literature review, synthesizing framework and future research agenda (2020) · cites this paper as Mamoshina et al., 2018

    In “Deep Learning for Data Quality and Consistency” (page unavailable), the paper says supervised anomaly-detection models require labelled data. It also describes unsupervised approaches as suitable for anomaly detection; it does not say its proposed approach underperforms on unlabelled datasets. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Prior literature suggested recommendations including extending/replicating frameworks and developing targeted treatment solutions.

    “Prior literature has suggested various recommendations for future research, including extending (e.g.Zhou et al., 2018) or replicating current frameworks (e.g.Quaini et al., 2018), and developing targeted treatment solutions (e.g.Mamoshina et al., 2018), to name a few.”

    From Blockchain in healthcare: A systematic literature review, synthesizing framework and future research agenda (2020) · cites this paper as Mamoshina et al., 2018

    The Conclusions propose using patient data and AI to develop diagnostic and treatment tools. The Introduction discusses personalized medicine, but the paper does not specifically recommend developing targeted treatment solutions. The other recommendations in the citing sentence are attributed to different sources. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Few studies proposed focusing on improving medical diagnostics and extending applications to other areas like rehabilitation.

    “Although algorithms exist for the deployment of blockchain that are geared towards improving healthcare processes, few studies have proposed the need for scholars to focus on the nuances of improving medical diagnostics (Mamoshina et al., 2018) and extending their application to other areas of healthcare, such as rehabilitation (Zheng et al., 2019).”

    From Blockchain in healthcare: A systematic literature review, synthesizing framework and future research agenda (2020) · cites this paper as Mamoshina et al., 2018

    The ‘Combination and Time Value of Data’ section identifies better, faster diagnostics and the search for suitable biomarkers as an important challenge. The Conclusions also envisage developing diagnostic tools. Neither passage says that few studies have proposed focusing on medical diagnostics; rehabilitation is attributed to Zheng et al., not this source. The indexed passages provide no page numbers. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Blockchain may assist in creating a viable information ecosystem for managing personal health records by incorporating heterogeneous forms of data, including medical big data.

    “Further, blockchain may assist in creating a viable information ecosystem for managing such PHRs (Mamoshina et al., 2018) by incorporating heterogeneous forms of data (Yue et al., 2016;Shen et al., 2019;Silva et al., 2019), including medical big data (Kaur et al., 2018).”
  • Prior studies implied that certain aspects of architectural frameworks for blockchain in healthcare can affect performance efficiency.

    “Studies have implied that certain aspects of architectural frameworks developed for adoption of blockchain in healthcare can affect the performance efficiency of the proposed framework (Ji et al., 2018;Mamoshina et al., 2018;Zhang & Lin, 2018).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • The cited 2015 proposal is listed as a 2017 review

    Minor

    The text attributes the proposed technique to a 2015 paper by Zhavoronkov et al., but reference 93 is a 2017 review led by Moskalev.

1 of 1

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. Gatenby, 2017, Fine-tuning convolutional deep features for MRI based brain tumor classification. Medical Imaging 2017: Computer-Aided Diagnosis, International Society for Optics and Photonics, 101342E
  2. Broekhuis, 2010, Barriers to the acceptance of electronic medical records by physicians from systematic review to taxonomy and interventions, BMC Health Services Research, 10, 231, 10.1186/1472-6963-10-231 · DOI · Paper page
  3. Breitinger, Gipp. Proceedings of the 15th Int. Symposium of B, 2017. VirtualPatent-Enabling the Traceability of Ideas Shared Online using Decentralized Trusted Timestamping. 2017. Available from: https://www.gipp.com/wp-content/papercite-data/pdf/breitinger2017.pdf.
  4. Shamir. Communications of the ACM A. 1979. How to share a secret. 1979 Available from: http://dl.acm.org/citation.cfm?id=359176.
  5. Blakley. Proceedings of the national computer 1979. Safeguarding cryptographic keys. 1979. Available from: https://pdfs.semanticscholar.org/32d2/1ccc21a807627fcb21ea829d1acdab23be12.pdf.
  6. Desmedt, 1992, Threshold cryptosystems. Advances in Cryptology — AUSCRYPT ’92, 1
  7. Vengertsev, Thakkar. Anomaly Detection in Graph: Unsupervised Learning, Graph-based Features and Deep Architecture. Available from: https://pdfs.semanticscholar.org/5049/920aeb54e481a865f9a9798b58706516fb10.pdf.

Cited by

Sorted by citations

Authors
Mamoshina, P., Ojomoko, L., Yanovich, Y., Ostrovski, A., Botezatu, A., Prikhodko, P., Izumchenko, E., Aliper, A., Romantsov, K., Zhebrak, A., Ogu, I. O., & Zhavoronkov, A.
Affiliations
  • Johns Hopkins University (US)
  • The Bitfury Group, Amsterdam, Netherlands
  • Insilico Medicine (United States) (US)
Venue
Oncotarget
Published
2017-11-09
Volume
9
Issue
5
Pages
5665-5690
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2767307339
Cited by
471
References
85
Citations by year
2026: 21 · 2025: 54 · 2024: 54 · 2023: 59 · 2022: 78 · 2021: 79 · 2020: 55 · 2019: 52 · 2018: 18 · 2017: 1
FWCI
64.26
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Oncotarget (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Computer Science › Information Systems › Blockchain Technology Applications and Security
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Computer Science › Information Systems › Blockchain Technology in Education and Learning
Keywords
blockchain, artificial intelligence, personal health data, decentralized data management, patient data ownership, data markets, biomedical research, drug discovery, biomarker development, deep learning, data value assessment, data regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review